← Back to catalogue

Safecup Iii 13 Panel

FDA UDI

Class II (US FDA UDI)

by Germaine Laboratories, Inc.

Identity

Trade Name
SAFECUP III 13 PANEL FDA UDI
Generic Name
Barbiturate IVD, kit, rapid ICT, clinical FDA UDI
Model / Reference
44433 FDA UDI

Identifiers

Primary DI / UDI-DI
00695684444334 FDA UDI
FDA Product Code
DJG FDA UDI
DIO FDA UDI
DIS FDA UDI
DJR FDA UDI
DKZ FDA UDI
LAF FDA UDI
LCM FDA UDI
LDJ FDA UDI
LFG FDA UDI
JXN FDA UDI
JXM FDA UDI
GMDN Term
Barbiturate IVD, kit, rapid ICT, clinical FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.3650 FDA UDI
862.3250 FDA UDI
862.3150 FDA UDI
862.3620 FDA UDI
862.3100 FDA UDI
862.3610 FDA UDI
862.3870 FDA UDI
862.3910 FDA UDI
862.3700 FDA UDI
862.3170 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Cannabinoid/cannabinoid metabolite IVD, kit, rapid ICT, clinicalCocaine/cocaine metabolite IVD, kit, rapid ICT, clinicalOpiate/opiate metabolite IVD, kit, rapid ICT, clinicalAmphetamine-specific IVD, kit, rapid ICT, clinical

Safecup Iii 13 Panel by Germaine Laboratories, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Propoxyphene IVD, kit, enzyme immunoassay (EIA).

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Germaine Laboratories, Inc.

Sources (1)

  • FDA UDI b0cd7cad-d554-4d4c-8c0a-beddf5d87b20 32 fields · synced Jun 1, 2026